Woodline Partners LP

Position in PEN — Penumbra Inc

CIK 1784547 San Francisco, CA

Position in PEN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$79,333,206

+$16,224,073 QoQ

Shares Held

241,597

+19.0% QoQ

Ownership

0.614%

of shares outstanding

% of Portfolio

0.31%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

14 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Woodline Partners LP holds $407,442,598 across 16 Medical Devices names. PEN ranks #2 (19.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EW	Edwards Lifesciences Corp	1,768,176	$141,595,534
2	PEN	Penumbra Inc This page	241,597	$79,333,206
3	SYK	Stryker Corp	128,378	$42,183,727
4	DXCM	Dexcom Inc	513,321	$32,236,558
5	ABT	Abbott Laboratories	286,108	$29,374,708
6	MASI	Masimo Corp	153,234	$27,255,731
7	BSX	Boston Scientific Corp	290,453	$18,225,925
8	ENOV	Enovis CORP	364,895	$8,301,361

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$79,333,206	241,597	+19.0%	Shares	Sole	2026-05-15
2025-12-31	$63,109,133	202,982	+39.1%	Shares	Sole	2026-02-17
2025-03-31	$39,010,038	145,881	+476.1%	Shares	Sole	2025-05-15
2024-12-31	$6,013,706	25,323	+396.0%	Shares	Sole	2025-02-14
2024-09-30	$991,952	5,105	-88.3%	Shares	Sole	2024-11-14
2023-09-30	$10,584,046	43,752	+341.7%	Shares	Sole	2023-11-14
2023-06-30	$3,408,258	9,906	-89.7%	Shares	Sole	2023-08-14
2022-12-31	$21,318,119	95,829	+61.0%	Shares	Sole	2023-02-14
2022-09-30	$11,282,716	59,508	+2.0%	Shares	Sole	2022-11-14
2022-03-31	$12,960,174	58,345	-19.7%	Shares	Sole	2022-05-16
2021-12-31	$20,868,626	72,632	+142.2%	Shares	Sole	2022-02-14
2021-09-30	$7,993,401	29,994	+117.7%	Shares	Sole	2021-11-15
2021-06-30	$3,775,724	13,777	-52.2%	Shares	Sole	2021-08-16
2021-03-31	$7,795,680	28,811	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.